Education
About Us
Working with TipRanks
Follow Us
InfuSystem Holdings, Inc. (INFU)
:INFU
INFU Stock Chart & Stats
Day’s Range― - ―
52-Week Range$5.29 - $9.97
Previous CloseN/A
Volume2.40K
Average Volume (3M)126.05K
Market Cap
$127.53M
Enterprise Value$177.54M
Total Cash (Recent Filing)$527.00K
Total Debt (Recent Filing)$4.56M
Price to Earnings (P/E)57.5
Beta1.41
Next Earnings
May 01, 2025EPS Estimate
-0.03Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.11
Shares Outstanding21,009,216
10 Day Avg. Volume122,846
30 Day Avg. Volume126,045
Financial Highlights & Ratios
PEG Ratio0.35
Price to Book (P/B)N/A
Price to Sales (P/S)0.92
Price to Cash Flow (P/CF)3.10
P/FCF Ratio3.10
Enterprise Value/Market Cap1.39
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit2.52
Enterprise Value/Ebitda11.12
Forecast
1Y Price Target
$13.75Price Target Upside127.65% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering3
---
InfuSystem Holdings, Inc. News
PremiumCompany Announcements
InfuSystem Holdings Reports Strong 2024 Financial Results
PremiumCompany Announcements
InfuSystem Holdings, Inc. Reports Strong Earnings Call
PremiumCompany Announcements
InfuSystem Holdings to Announce 2024 Financial Results
PremiumCompany Announcements
InfuSystem Achieves Five Years of Record Revenue Growth---
Bulls Say, Bears Say
Bulls Say
Financial PerformanceThe Company showed notable progress in gross margin improvement of 122 basis points Y/Y and AEBITDA margin improvement of 282 basis points Y/Y.
Operating Cash FlowOperating cash flow was $20.5M in 2024, an 82% increase Y/Y.
Bears Say
EarningsEPS of $0.04 was below our estimate and consensus of $0.08 and $0.09, respectively.
RevenueRevenue came in below our forecast and consensus due to delays in onboarding new wound care initiatives as the Company looks to improve referral processes with newer partners.
---
Ownership Overview
9.25% Insiders
17.98% Mutual Funds
30.77% Other Institutional Investors
32.87% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
INFU FAQ
What was InfuSystem Holdings, Inc.’s price range in the past 12 months?
InfuSystem Holdings, Inc. lowest stock price was $5.29 and its highest was $9.97 in the past 12 months.
What is InfuSystem Holdings, Inc.’s market cap?
InfuSystem Holdings, Inc.’s market cap is $127.53M.
When is InfuSystem Holdings, Inc.’s upcoming earnings report date?
InfuSystem Holdings, Inc.’s upcoming earnings report date is May 01, 2025 which is in 35 days.
How were InfuSystem Holdings, Inc.’s earnings last quarter?
InfuSystem Holdings, Inc. released its earnings results on Mar 04, 2025. The company reported $0.04 earnings per share for the quarter, missing the consensus estimate of $0.075 by -$0.035.
Is InfuSystem Holdings, Inc. overvalued?
According to Wall Street analysts InfuSystem Holdings, Inc.’s price is currently Undervalued.
Does InfuSystem Holdings, Inc. pay dividends?
InfuSystem Holdings, Inc. does not currently pay dividends.
What is InfuSystem Holdings, Inc.’s EPS estimate?
InfuSystem Holdings, Inc.’s EPS estimate is -0.03.
How many shares outstanding does InfuSystem Holdings, Inc. have?
InfuSystem Holdings, Inc. has 21,009,216 shares outstanding.
What happened to InfuSystem Holdings, Inc.’s price movement after its last earnings report?
InfuSystem Holdings, Inc. reported an EPS of $0.04 in its last earnings report, missing expectations of $0.075. Following the earnings report the stock price went down -10.882%.
Which hedge fund is a major shareholder of InfuSystem Holdings, Inc.?
Currently, no hedge funds are holding shares in INFU
---
InfuSystem Holdings, Inc. Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$13.75 (127.65% Upside)
$13.75 (127.65% Upside)
Blogger Sentiment
Bullish
INFU Sentiment 100%
Sector Average 69%
Sector Average 69%
Hedge Fund Trend
Increased
By 186.7K Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Very Negative
Last 7 Days ▼ 1.2%
Last 30 Days ▼ 11.9%
Last 30 Days ▼ 11.9%
News Sentiment
Neutral
Bullish news 50%
Bearish news 100%
Bearish news 100%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-29.71%
12-Months-Change
Fundamentals
Return on Equity
4.27%
Trailing 12-Months
Asset Growth
0.91%
Trailing 12-Months
Company Description
InfuSystem Holdings, Inc.
InfuSystem Holdings, Inc., through its subsidiaries, provides infusion pumps, and related products and services in the United States and Canada. The company operates in two segments, Integrated Therapy Services (ITS) and Durable Medical Equipment Services (DME Services). It supplies electronic ambulatory infusion pumps and associated disposable supply kits to oncology, infusion, and hospital outpatient chemotherapy clinics for the treatment of various cancers, including colorectal cancer, pain management, and other disease states. The company also sells, rents, and leases new and pre-owned pole-mounted and ambulatory infusion pumps, and other durable medical equipment; sells treatment-related consumables; and provides biomedical recertification, maintenance, and repair services for oncology practices, as well as other alternate site settings comprising home care and home infusion providers, skilled nursing facilities, pain centers, hospital market, and others. In addition, it offers local and field-based customer support, as well as operates pump service and repair centers. The company was incorporated in 2005 and is headquartered in Rochester Hills, Michigan.
---
INFU Earnings Call
Q4 2025
0:00 / 0:00
Earnings Call Sentiment|Positive
InfuSystem Holdings, Inc. showed strong financial growth with significant increases in revenue, operating income, and adjusted EBITDA. The company also achieved a record operating cash flow and demonstrated potential for future growth with the launch of the Chemo Mouthpiece. However, challenges such as high tax rates and underperformance in the wound care segment were noted, along with the anticipated costs of an ERP upgrade. Overall, the company's highlights outweigh the lowlights, indicating a positive outlook.Read More>---
INFU Stock 12 Month Forecast
Average Price Target
$13.75
▲(127.65% Upside)
Technical Analysis
Best Analysts Covering INFU
1 Year
1 Year Success Rate
4/11 ratings generated profit
1 Year Average Return
-5.92%
reiterated a buy rating 23 days ago
Copying Brooks O'Neil's trades and holding each position for 1 Year would result in 36.36% of your transactions generating a profit, with an average return of -5.92% per trade.
---